Clinical trial
The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates Born to Mother With Positive for Both HBsAg and HBeAg, Positive for HBsAg But Negative for HBeAg, Negative for HBsAg, HBeAg, HBeAb and HBcAb
NCT01183611 is registered in ClinicalTrials.gov with Jiangsu Province Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates Born to Mother With Positive for Both HBsAg and HBeAg, Positive for HBsAg But Negative for HBeAg, Negative for HBsAg, HBeAg, HBeAb and HBcAb
- Lead sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- September 30, 2010
- Enrollment
- 1,740 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dna virus infections, hepadnaviridae infections, virus disease